Literature DB >> 29492850

RETRACTED ARTICLE: Combination Antiemetic Regimens for Prevention of Postoperative Nausea and Vomiting : Focus on High-Risk Patients.

Yoshitaka Fujii1.   

Abstract

None of the available antiemetics is entirely effective, perhaps because most of them act through the blockade of one receptor. There is a possibility that a combination of antiemetics with different sites of activity would be more effective than one drug alone for prophylaxis against postoperative nausea and vomiting (PONV).The clinical use of combined traditional antiemetics, including antihistamines (e.g. diphenhydramine), butyrophenones (e.g. droperidol) and benzamides (e.g. metoclopramide), for the prevention of PONV is limited because of the possibility of additive central nervous system toxicity, such as delayed emergence, drowsiness and extrapyramidal reactions. The efficacy of a combination of a serotonin 5-HT3 receptor antagonist (ondansetron, granisetron or tropisetron) and dexamethasone is superior to that of 5-HT3 receptor antagonists alone for the prevention of PONV, suggesting that dexamethasone enhances the antiemetic efficacy of 5-HT3 receptor antagonists. The combination of a 5-HT3 receptor antagonist with a traditional antiemetic (droperidol, metoclopramide or promethazine) acting at a different emetogenic receptor is more effective in reducing the incidence of PONV than each antiemetic alone acting at one receptor site. The risk of undesirable adverse effects does not increase with the combination of a 5-HT3 receptor antagonist and a traditional antiemetic at the doses commonly used for PONV, because of the absence of drug interactions. The combination of a 5-HT3 receptor antagonist (ondansetron) with other agents (propofol and CP-122721) reduces the incidence of PONV to a greater degree than monotherapy. However, no data are available for the combination of 5-HT3 receptor antagonists and small doses of propofol for the prevention of PONV.Further studies are needed to evaluate the efficacy and safety of combination antiemetic regimens for PONV. Knowledge regarding combinations of these antiemetic drugs may be necessary to completely prevent PONV.

Entities:  

Keywords:  Droperidol; Granisetron; Metoclopramide; Ondansetron; Tropisetron

Year:  2002        PMID: 29492850     DOI: 10.2165/00044011-200222090-00001

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN: 1173-2563            Impact factor:   2.859


  65 in total

Review 1.  Current management of postoperative nausea and vomiting.

Authors:  D J Rowbotham
Journal:  Br J Anaesth       Date:  1992       Impact factor: 9.166

2.  A comparison of costs and efficacy of ondansetron and droperidol as prophylactic antiemetic therapy for elective outpatient gynecologic procedures.

Authors:  J Tang; M F Watcha; P F White
Journal:  Anesth Analg       Date:  1996-08       Impact factor: 5.108

3.  Combination of ondansetron and droperidol in the prophylaxis of postoperative nausea and vomiting.

Authors:  F J Pueyo; F Carrascosa; L Lopez; M J Iribarren; F García-Pedrajas; A Saez
Journal:  Anesth Analg       Date:  1996-07       Impact factor: 5.108

Review 4.  The current role of anti-emetic drugs in oncology: a recent revolution in patient symptom control.

Authors:  S M Sagar
Journal:  Cancer Treat Rev       Date:  1991-06       Impact factor: 12.111

5.  Granisetron-droperidol combination for the prevention of postoperative nausea and vomiting in female patients undergoing breast surgery.

Authors:  Y Fujii; H Toyooka; H Tanaka
Journal:  Br J Anaesth       Date:  1998-09       Impact factor: 9.166

6.  Granisetron/dexamethasone combination for reducing nausea and vomiting during and after spinal anesthesia for cesarean section.

Authors:  Y Fujii; Y Saitoh; H Tanaka; H Toyooka
Journal:  Anesth Analg       Date:  1999-06       Impact factor: 5.108

7.  Comparison of anti-emetic effects of ondansetron, metoclopromide or a combination of both in children undergoing surgery for strabismus.

Authors:  S Kathirvel; D Shende; R Madan
Journal:  Eur J Anaesthesiol       Date:  1999-11       Impact factor: 4.330

Review 8.  Metoclopramide: a review of its pharmacological properties and clinical use.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

9.  Prophylactic antiemetic therapy with granisetron-dexamethasone combination in women undergoing breast surgery.

Authors:  Y Fujii; H Tanaka; H Toyooka
Journal:  Acta Anaesthesiol Scand       Date:  1998-10       Impact factor: 2.105

10.  Cost-effectiveness analysis of antiemetic therapy for ambulatory surgery.

Authors:  M F Watcha; I Smith
Journal:  J Clin Anesth       Date:  1994 Sep-Oct       Impact factor: 9.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.